Legal & General Group
VAXX

Legal & General Group’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Legal & General Group’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,269
Closed -$3.78K – 3568
2024
Q1 		$3.78K Hold
5,269
– – ﹤0.01% 3316
2023
Q4 		$4.5K Hold
5,269
– – ﹤0.01% 3331
2023
Q3 		$7.22K Hold
5,269
– – ﹤0.01% 3324
2023
Q2 		$13.3K Buy
+5,269
New +$11.2K ﹤0.01% 3265

Other funds holding VAXX

SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
RF
Robinswood Financial Kirkland, Washington $349M AUM 14.9% 1-Year Est. Return

Legal & General Group's VAXX Position: Q2 2024 in Review

Legal & General Group sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2024, closing a stake of 5,269 shares — an estimated $3.78K sold.

Legal & General Group first reported a position in VAXX in Q2 2023 and held it in 4 quarters. The position peaked at $13.3K in Q2 2023. 8 funds tracked by Wall St. Rank hold VAXX as of Q2 2024.

  • Legal & General Group reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
  • Legal & General Group sold 5,269 Vaxxinity, Inc. Class A Common Stock shares in Q2 2024, an estimated $3.78K.
  • Legal & General Group first reported a position in Vaxxinity, Inc. Class A Common Stock in Q2 2023 and held it in 4 quarters.
  • Legal & General Group's Vaxxinity, Inc. Class A Common Stock position peaked at $13.3K in Q2 2023.
  • 8 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2024.

Based on Legal & General Group's 13F filing for Q2 2024, filed 14 Aug 2024.